U.S. markets closed

ReShape Lifesciences Inc. (RSLS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.1200+0.1500 (+5.05%)
At close: 4:00PM EDT
3.1500 +0.03 (+0.96%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close2.9700
Bid3.1100 x 1200
Ask3.1000 x 1000
Day's Range2.8700 - 3.1899
52 Week Range0.7200 - 10.7700
Avg. Volume2,669,462
Market Cap49.428M
Beta (5Y Monthly)1.66
PE Ratio (TTM)N/A
EPS (TTM)-3.0190
Earnings DateNov 04, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for RSLS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ReShape Lifesciences, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/23/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • GlobeNewswire

    ReShape Launches National Advertising Campaign for Flagship Product, Lap-Band®

    The Company’s first and largest mainstream mass-market advertising campaign Featured on major television channels and consumer print publications SAN CLEMENTE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced the launch of a multi-platform consumer advertising campaign utilizing national television, print, social media, and public relations to market their Next-Generation La

  • GlobeNewswire

    ReShape Lifesciences™ Featured in BioTuesdays

    RSLS Market Slide Image Physician Led Opportunity in the Weight Loss Continuum SAN CLEMENTE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company was highlighted in this week’s BioTuesdays feature article, titled “ReShape Lifesciences forging weight loss and metabolic health solutions”. The article stemmed from ReShape Lifesciences CEO Bart Bandy’s interview with BioTuesdays’ Edito

  • GlobeNewswire

    ReShape Lifesciences™ to Host Exhibit at Bariatric Summit

    ReShape Director of reshapecare™ Heather Mackie will be speaking at the conferenceSAN CLEMENTE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company will host an exhibit at the upcoming 17th Annual Bariatric Summit in Washington, D.C. September 18-19, 2021. ReShape Senior Director of reshapecare™ Heather Mackie, MS, RDN, LD will be presenting and participating in focal patient care